We are live on ! Find out more
WRM

Weybosset Research & Management Portfolio holdings

AUM $381M
1-Year Est. Return 42.16%
This Fund
S&P 500
This Quarter Est. Return
+18.94%
1 Year Est. Return
+42.16%
3 Year Est. Return
+73.45%
5 Year Est. Return
10 Year Est. Return
AUM
$171M
AUM Growth
+$30.3M
Cap. Flow
-$54.9M
Cap. Flow %
-32.18%
Top 10 Hldgs %
54.26%
Holding
57
New
4
Increased
17
Reduced
23
Closed
6

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$621K
2
STZ icon
Constellation Brands
STZ
+$541K
3
HXL icon
Hexcel
HXL
+$503K
4
APTV icon
Aptiv
APTV
+$404K
5
PG icon
Procter & Gamble
PG
+$252K

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$54.3M
2
CPRT icon
Copart
CPRT
+$477K
3
PFE icon
Pfizer
PFE
+$410K
4
MCD icon
McDonald's
MCD
+$359K
5
MMM icon
3M
MMM
+$299K

Sector Composition

Rank Sector Weight
1 Industrials 35.92%
2 Technology 13.5%
3 Financials 13.41%
4 Healthcare 9.02%
5 Consumer Discretionary 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
51
McDonald's
MCD
$195B
-2,263
Closed -$359K
MMM icon
52
3M
MMM
$94.4B
-2,691
Closed -$299K
PFE icon
53
Pfizer
PFE
$152B
-13,593
Closed -$410K
UPS icon
54
United Parcel Service
UPS
$89.3B
-3,260
Closed -$297K
WELL icon
55
Welltower
WELL
$171B
-6,650
Closed -$276K
RTN
56
DELISTED
Raytheon Company
RTN
-2,080
Closed -$256K

Similar funds

Weybosset Research & Management's Q2 2020 Portfolio in Review

As of Q2 2020, Weybosset Research & Management held 57 positions worth $171M, up 22% from $140M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Weybosset Research & Management withdrew a net $54.9M in Q2 2020, closing 6 positions and reducing 23 holdings. Its most notable exit was Pfizer, an estimated $410K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 36% of assets, down from 37% a quarter earlier, followed by Technology and Financials.

Against the trend, Weybosset Research & Management opened a new position in Constellation Brands worth $330K.

  • Weybosset Research & Management's largest Q2 2020 buy was Constellation Brands: 3,250 shares worth $330K.
  • Weybosset Research & Management added most to JPMorgan Chase in Q2 2020, an estimated $621K increase.
  • Weybosset Research & Management's biggest Q2 2020 reduction was Berkshire Hathaway Class A, cutting an estimated $54.3M.
  • Weybosset Research & Management fully exited Pfizer in Q2 2020, selling an estimated $410K.
  • Weybosset Research & Management's ten largest holdings make up 54% of its $171M portfolio in Q2 2020.
  • Weybosset Research & Management opened 4 new positions and closed 6 in Q2 2020.
  • Weybosset Research & Management's portfolio value rose 22% quarter-over-quarter to $171M.

Based on Weybosset Research & Management's 13F filing for Q2 2020, filed 22 Jul 2020.